🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Genomics & Personalized Medicine

Benchmark revenue and EBITDA valuation multiples for public comps like Natera, Guardant Health, Twist Bioscience, BGI Genomics and Genus.

Genomics & Personalized Medicine

See analyst estimates and all valuation multiples for Genomics & Personalized Medicine
Company EV EV/Revenue EV/EBITDA
$20.0B 11.1x -84.4x
$14.1B 3.3x 12.2x
$11.9B 4.1x 32.4x
$5.7B 7.2x -23.4x
$2.9B 5.2x 104.2x
$2.1B 2.4x 13.8x
$2.1B 4.4x 20.9x
$1.8B 5.0x -12.2x
$1.7B 5.2x 76.9x
$1.0B 1.6x 17.0x
$841M 1.4x -5.4x
$819M 6.1x -0.8x
$701M 4.5x -3.0x
$697M 2.0x 23.8x
$644M 2.1x 12.3x
$445M 0.5x 13.1x
$404M 54.3x -4.4x
$393M 4.5x n/a
$336M 6.6x -5.4x
$328M 2.2x -1.6x
$313M 3.7x -4.5x
$305M 1.0x -32.2x
$259M n/a n/a
$253M n/a n/a
$242M 0.8x 4.9x
$241M 100.9x -15.2x
$233M 54.3x -43.9x
$200M 10.8x n/a
$199M 66.9x n/a
$170M 2.5x -4.3x
$157M n/a n/a
$144M 22.5x -0.8x
$94.1M 1.7x -1.3x
$91.5M n/a -0.6x
$87.5M 18.6x -0.5x
$76.3M 30.5x n/a
$31.7M 0.7x 4.9x
$25.7M 0.5x -0.4x
$18.1M n/a n/a
$12.3M 17.1x -0.1x
$10.1M n/a n/a
$9.7M 0.3x -0.2x
$2.6M 1.6x -0.0x
-$2.0M -0.0x 0.1x
-$2.7M n/a n/a
-$11.1M n/a 0.1x
-$12.5M -0.2x 0.1x
-$14.7M -22.7x 0.2x
-$17.6M n/a 0.2x
-$32.9M n/a n/a
-$41.9M n/a 0.5x
-$43.7M -2.4x n/a
-$64.3M -2.5x 0.3x
-$83.5M -2.8x 0.3x
-$90.1M -4.0x n/a
-$109M -11.0x 0.7x
-$143M -3.1x 1.6x

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Genomics & Personalized Medicine

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.